Tips

九月美迪西将主办2场线上主播主播，同时参与15场海里外餐饮行业电视电话会议，期待与各位业内同仁交流分享药物研发新趋势。

第十二届药物毒理学年会

由中国药理学会药物毒理专业委员会主办的“第10二届药物治疗毒理学年终晚会”将于2026年4月1日至3日在上海市光大会展中心召开。

为推动毒理学前沿研究进展和成果转化，美迪西专家将从一般的毒理学、好根治口服性药物、口服性药物GLP制约与产品确定等研究方向，在相应主题分会场带来3场精彩绝伦演讲主题，同时展出1项探究壁报，希望通过此次重要的毒理学术盛会，与行业专家深入交流和分享最新的研究成果。

EFMC-ISMC 2024

The XXVIII EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2024) is organised by the Medicinal Chemistry Division of Italian Chemical Society, on behalf of the European Federation for Medicinal chemistry and Chemical biology (EFMC). The symposium will take place in Rome, Italy from September 1-5, 2024. The EFMC is the main organisation for the European Medicinal Chemistry and Chemical Biology community, with 30 member societies and about 9.000 members. Its biennial EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery, and it traditionally attracts around 1.000 participants both from industry and academia. The scientific programme of EFMC-ISMC 2024 will furthermore cover a wide range of selected topics with parallel sessions split into three main themes: 1) Chemical Biology; 2) Drug Discovery Pojects; 3) Technologies.

Medicilon is thrilled to exhibit in the conference. Dr. Paul van Stralen, VP of Strategic Collaborations EMEA at , will be available throughout the conference. We invite you to visit us at Medicilon Booth #6 to explore our services and capabilities.

EUROTOX 2024

We are pleased to announce that Medicilon will exhibit in the EUROTOX 2024 with the Booth #43. The congress will take place from 8 to 11 September 2024 at Copenhagen, Denmark. The congress theme “Toxicology - A Quest for safe Chemicals and Medicines” reflects the congress programme including a variety of topics dealing with safety of drugs and environmental chemicals, new and emerging technologies, personalised medicine, human health effects caused by exposure to chemicals as well as safety issues arising from climate changes. Dr. Renzong Xie, Vice President of Medicilon Quality Assurance Department, and Medicilon team will be present throughout the conference. Please stop by at our booth and discuss how Medicilon’s services and capabilities could support your research needs and expedite your drug discovery and development process.

PBSS Workshop

The landscape of disease-treatment modalities has undergone a dramatic transformation in recent years. New therapeutic modalities, with innovative mechanisms of action, are revolutionizing patient care. Some of these advancements extend beyond traditional small molecules and antibodies to encompass exciting areas like bispecific antibodies, ADCs and gene therapies. Even within the small molecule realm, covalent binders, biased agonists and pan-inhibitors are pushing the boundaries of our understanding of pharmacokinetic (PK)/pharmacodynamic (PD) relationships. In addition to this, therapeutics that are intended for ocular and neuro delivery put forth challenges associated with delivering desired drug concentrations at the site of action. Medicilon team will be present throughout the event.

2024香港国际生物科技论坛展览 

BIOHK 2024其三届天津知名怪物学科技开发开发论坛社区暨展览会当作天津怪物学科技开发开发展览会的典范展览会，将于5月11-14在天津展览中心的中心的举行。

美迪西开发团队将在3E-C10号标准展位等待图片全球同仁的大驾光临！

2024第三届国际生物医药产业发展大会 

以“加强团结跨文化课技术创新，质量保障地球不断正常”侧重于题的第二届新国际生物学医疗器械产业群成长 博览会，将于2021年-9月12-14祝日重庆创办。❖ 美迪西顶尖专业馆彭双清硕士生导师将受聘美迪西英才教育“山河会”圆餐桌交流论坛著名主持人人，并参加一个沟通步骤；❖ 美迪西药制剂部高阶主管&药物注测部副经理王丹博后将到场投稿演讲赛；❖ 美迪一些西药效部内容营销经理袁芸芸教授将到场刊登讲演。

2024 BioSpark Annual Conference

BioSpark will host the 2024 Annual Conference on Saturday, September 14 at Cambridge, MA. The conference theme this year is “Braving through the Winter of Biotech”, and will bring together professionals from the biotech industry to discuss the latest trends and innovations. Whether you're a seasoned expert or just starting out in the field, this event is perfect for anyone looking to stay ahead in the world of biotechnology. Medicilon is excited to attend and exhibit at the conference. Dr. Qingcong Lin, President of Medicilon USA Corp., will give a presentation. Dr. Lin brings nearly 40 years of experience in pharmaceutical R&D, making significant contributions to both academia and the global industry. Medicilon team will be present throughout the event. 

26th North American ISSX and 39th JSSX Meeting

Meet Medicilon at 26th North American ISSX and 39th JSSX Meeting. As the foremost organization representing the interests of researchers and educators in DMPK and other related areas of research, the International Society for the Study of Xenobiotics (ISSX) is engaged in multiple activities to support, promote, and advance the science worldwide.  ISSX has an international base of members from more than 45 countries. Members are comprised fairly evenly between academic and industry groups and consist primarily of research scientists and future scientists in toxicology, pharmacology, molecular biology, and other disciplines related to the study of xenobiotics. During the Conference, Dr. Pin Jiang, Senior Director of DMPK at Medicilon, will present the poster titled "Enhancing Drug-Drug Interaction Prediction by Integrating Physiologically-Based Pharmacokinetic Model with Fraction Metabolized by CYP3A4". Medicilon team will be present throughout the event. 

第八届全国核酸疫苗大会

中国有肺炎接种预防针的业协会网站核酸肺炎接种预防针协会将于202多年3月19日-22日为天津设立8届广东省性核酸肺炎接种预防针年会。另行通知年会的题材为“栉风沐雨发展壮大 ·笃行致远”，激情邀请人广东省性关于方向权威专家、研究者、科技带头人、工业企业代理列席学习交流。美迪西管理团队将在A02号展台设计等待时间产业界同仁的远道而来！

PBSS Workshop

With the advent of complex biologics and the increasing use of novel modalities over traditional antibodies during drug development, it has become critical to develop our understanding on their unique safety assessments and challenges. The intent of this workshop is to enlighten to develop an understanding of toxicity risk assessments and share latest progress in the field of biologics to activate discussions that will lead to more successful IND/BLA submissions. Medicilon team will be present throughout the event.

BioForward 2024

Meet Medicilon at BioForward 2024! BioForward is OBN's 'Roadmap for Growth' Life Sciences event, designed to provide the support, skills, know-how and industry connections required to catalyse the growth of your company. Now in its sixth year, BioForward is attended by leaders and decision makers of growing R&D companies across all therapy and technological areas, alongside companies who provide the specialist services, products, advice and expertise essential for all companies as they grow. Medicilon is excited to attend and exhibit at the conference. Dr. Wenjie Li, Vice President of the CMC Unit at Medicilon, PARTNERING WITH THE RIGHT MANUFACTURER TO ACCELERATE YOUR RESEARCH" at 14:35-14:55 local time during Workshop Session 6 - Partnering with the right manufacturer to accelerate your research.

第九届国际药物研究与发展新兴技术大会（IAPC-9）

IAPC-9由香港国际物理防御电化学家协会网站、ADMET 和 DMPK Journal 举办单位，天津大专基础医学院、重庆交通银行大专基础医学院、美迪西和腾迈联新聯合举办单位。这回大会的心中话题是“药物剂量剂量找到和搭建建设的兴新的工艺”，此次传布和分享视频药物剂量剂量找到和搭建建设的领域的新的工艺和研究软件平台。美迪西是 这次的座谈会的承办方公司的，将一直在展台等候区块链行业同仁的光顾！

第三届BIONNOVA北京创新论坛

时维十二月，岁月流金，三届BIONNOVA深圳不断创新论坛网将于朗丽兹西山园艺酒店餐厅关闭全新的篇章！美迪西总裁实验官彭双清专家将亮相说出演讲题目，同一美迪西的团队将全线设展，看好与 您继续相会！

2024 SAPA Annual Conference

Sino-American Pharmaceutical Professionals Association (SAPA) will host the 2024 Annual Conference on Friday & Saturday, September 27 & 28 at Hyatt Regency New Brunswick, 2 Albany St, New Brunswick, New Jersey. The conference theme this year is “Redefining Medicine: Navigating Resilience, Transforming Lives”, and will include plenary sessions and 7 panel discussions such as Investment/Business Development, Drug Discovery, CMC, Clinical Development/Regulatory, Career Development, Executive/Legal, Artificial Intelligence (AI), and plenty of networking opportunities.  During the SAPA SAPA Annual Conference, Dr. Wenjie Li, Vice President of the CMC Unit at Medicilon, will participate in the panel discussion "CMC and Outsourcing". Dr. Qingcong Lin, President of Medicilon USA Corp., and Medicilon team will be present throughout the conference. 

DOT 2024

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. DOT 2024 four-day event brings back popular topics like kinases, immunomodulation, and degraders, plus new coverage of covalent chemistries and induced proximity, synthetic biology, cancer antibodies, generative AI, and translational models. We looks forward to meeting you from September 30-October 3 in Boston, MA. Medicilon is experienced with oncology drug in any preclinical phases, from hit-to-lead to IND. We provide integrated service strategies for sponsors’ oncology drug discovery and development pipelines. We aim to enhance every step in preclinical search and to deliver real time data.

marketing@czchengteng.com媒体与会务请联系
美迪西市场部微信或邮箱